Novo Nordisk - ADR

+2.55 (+2.89%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)162.01B
Current PE3.78
Forward PE 29.19
2yr Forward PE 26.39
See more stats
Estimates Current Quarter
Revenue$5.21 Billion
Adjusted EPS$0.80
See more estimates
10-Day MA$88.10
50-Day MA$83.39
200-Day MA$73.45
See more pivots

Novo Nordisk - ADR Stock, NYSE:NVO

Novo All?©, Novo All?©, Bagsv??rd, Capital Region 2880
Phone: +
Number of Employees: 45323


Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsv??rd, Denmark.